Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Bullboard Posts
Comment by INVESTOR1999on Aug 27, 2019 11:07pm
96 Views
Post# 30073160

RE:RE:RE:RE:RE:Free Fall

RE:RE:RE:RE:RE:Free FallI would keep the baby close by and keep the water.  There is profit to be made in the near term and long term. Stay tuned. 


lscfa wrote: MediPharm is now trading at 14 x 2020 eps of $0.31 which is cheap considering the co. will grow by 50% from 2020 to 2021. 


 
Geo1967 wrote:
Hey lscfa, good to hear you on here. I respect your input so
being one of the longs here, do you see this bouncing back and still consider this a long hold. I’m liking LABS the most, but hell its been a tough 2 weeks. Thanks

lscfa wrote: Throwing the baby out with the bath water. Idiot stock market lumping all cannabis-related co.s in the same group as cant-trust.   
 
 

 


[/quote]

Bullboard Posts